CCL2 and inflammatory bowel disease: Pro-inflammatory cytokines, including IL-6, TNF-α, IL-1β, IL-17, IFN-γ and chemokine MCP-1, are key drivers of IBD pathology, contributing to immune cell recruitment, tissue damage, mucosal injury and systemic inflammation [37,38].